Metro Healthcare Indonesia
PT Metro Healthcare Indonesia Tbk owns, operates, and manages hospitals in Indonesia. It provides the management of hospitals, clinics, treatment hall, polyclinics, and other medical centers; physical medicine and trading; industry, development, and services; professional, scientific, technical, financial, and investment services; transportation, workshop, forestry, and agriculture services; heal… Read more
Metro Healthcare Indonesia (CARE) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.005x
Based on the latest financial reports, Metro Healthcare Indonesia (CARE) has a cash flow conversion efficiency ratio of 0.005x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Rp16.50 Billion) by net assets (Rp3.02 Trillion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Metro Healthcare Indonesia - Cash Flow Conversion Efficiency Trend (2016–2024)
This chart illustrates how Metro Healthcare Indonesia's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Metro Healthcare Indonesia Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Metro Healthcare Indonesia ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen hongfuhan Technology Co. Ltd.
SHE:301086
|
N/A |
|
Mesabi Trust
NYSE:MSB
|
0.514x |
|
Henan Taloph Pharmaceutical Stock Co Ltd
SHG:600222
|
0.014x |
|
Dynamatic Technologies Limited
NSE:DYNAMATECH
|
0.068x |
|
Harbin Xinguang Optic Electronics
SHG:688011
|
0.001x |
|
ZimVie Inc
NASDAQ:ZIMV
|
0.008x |
|
IRPC Public Company Limited
BK:IRPC
|
0.028x |
|
QuantumScape Corporation
SA:Q2SC34
|
-0.207x |
Annual Cash Flow Conversion Efficiency for Metro Healthcare Indonesia (2016–2024)
The table below shows the annual cash flow conversion efficiency of Metro Healthcare Indonesia from 2016 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Rp3.02 Trillion | Rp-113.01 Billion | -0.037x | -39.68% |
| 2023-12-31 | Rp3.10 Trillion | Rp-83.03 Billion | -0.027x | +8.17% |
| 2022-12-31 | Rp3.21 Trillion | Rp-93.60 Billion | -0.029x | -304.27% |
| 2021-12-31 | Rp3.30 Trillion | Rp47.13 Billion | 0.014x | -6.52% |
| 2020-12-31 | Rp3.29 Trillion | Rp50.30 Billion | 0.015x | +251.23% |
| 2019-12-31 | Rp2.27 Trillion | Rp-22.98 Billion | -0.010x | -100.95% |
| 2018-12-31 | Rp-27.14 Billion | Rp-29.03 Billion | 1.069x | +170.88% |
| 2017-12-31 | Rp11.34 Billion | Rp-17.10 Billion | -1.509x | -1462248.40% |
| 2016-12-31 | Rp10.62 Billion | Rp-1.10 Million | 0.000x | -- |